
Détail de l'auteur
Auteur S. HUTCHINSON |
Documents disponibles écrits par cet auteur (12)

![]()
Article : Périodique
L. PLATT ; J. REED ; S. MINOZZI ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; M. HICKMAN |This is the protocol for a review and there is no abstract. The objectives are as follows: 1. To assess the impact of needle/syringe programmes with and without opiate substitution therapy (OST) on the incidence of HCV infection among people w[...]![]()
Article : Périodique
N. E. PALMATEER ; J. KIMBER ; M. HICKMAN ; S. HUTCHINSON ; T. RHODES ; D. GOLDBERG |AIMS: To review the evidence on the effectiveness of harm reduction interventions involving the provision of sterile injecting equipment in the prevention of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) transmission among injec[...]![]()
Article : Périodique
A. TAYLOR ; D. GOLDBERG ; S. HUTCHINSON ; S. CAMERON ; R. FOX |In 1988, the UK Departments of Health gave approval for sterile needles and syringes to be made available to injecting drug users, thus obviating their need to inject with used equipment.1 Since then, several hundred needle/syringe exchange sche[...]![]()
Article : Périodique
Z. WARD ; L. PLATT ; S. SWEENEY ; V. D. HOPE ; L. MAHER ; S. HUTCHINSON ; N. PALMATEER ; J. SMITH ; N. CRAINE ; A. TAYLOR ; N. MARTIN ; R. AYRES ; J. DILLON ; M. HICKMAN ; P. VICKERMAN |Aims: To estimate the impact of existing high-coverage needle and syringe provision (HCNSP, defined as obtaining more than one sterile needle and syringe per injection reported) and opioid substitution therapy (OST) on hepatitis C virus (HCV) tr[...]![]()
Article : Périodique
N. PALMATEER ; V. HAMILL ; A. BERGENSTROM ; H. BLOOMFIELD ; L. GORDON ; J. STONE ; H. FRASER ; T. SEYLER ; Y. DUAN ; R. TRAN ; K. TRAYNER ; C. BIGGAM ; S. SMITH ; P. VICKERMAN ; M. HICKMAN ; S. HUTCHINSON |Background: Hepatitis C virus (HCV) and HIV remain prevalent among people who inject drugs (PWID) and transmission is usually associated with injecting risk behaviour (IRB). We update a 2011 review of reviews (RoR) to assess the latest evidence [...]![]()
Article : Périodique
H. FRASER ; N. K. MARTIN ; H. BRUMMER-KORVENKONTIO ; P. CARRIERI ; O. DALGARD ; J. DILLON ; D. GOLDBERG ; S. HUTCHINSON ; M. JAUFFRET-ROUSTIDE ; M. KABERG ; A. A. MATSER ; M. MATICIC ; H. MIDGARD ; V. MRAVCIK ; A. OVREHUS ; M. PRINS ; J. REIMER ; G. ROBAEYS ; B. SCHULTE ; D. K. VAN SANTEN ; R. ZIMMERMANN ; P. VICKERMAN ; M. HICKMAN |BACKGROUND & AIMS: Prevention of hepatitis C virus (HCV) transmission among people who inject drugs (PWID) is critical for eliminating HCV in Europe. We estimated the impact of current and scaled-up HCV treatment with and without scaling up opio[...]![]()
Article : Périodique
Mortality and cause of death in a cohort of people who had ever injected drugs in Glasgow: 1982-2012
D. NAMBIAR ; A. WEIR ; E. J. ASPINALL ; M. STOOVE ; S. HUTCHINSON ; P. DIETZE ; L. WAUGH ; D. J. GOLDBERG |Background: To describe all-cause and cause-specific mortality in a cohort of people who had ever injected drugs (PWID) with a low prevalence of HIV over 20-30 years. Methods: Using a retrospective study design, identifying data from a cohort o[...]Nouveauté
![]()
Article : Périodique
L. PLATT ; S. MINOZZI ; J. REED ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; J. BRUNEAU ; M. HICKMAN |Aims: To estimate the effects of needle and syringe programmes (NSP) and opioid substitution therapy (OST), alone or in combination, for preventing acquisition of hepatitis C virus (HCV) in people who inject drugs (PWID). Methods: Systematic re[...]![]()
Article : Périodique
L. PLATT ; S. MINOZZI ; J. REED ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; J. BRUNEAU ; M. HICKMAN |Review question: We examine research on the effect of needle syringe programmes (NSP) and opioid substitution treatment (OST) in reducing the risk of becoming infected with the hepatitis C virus. Background: There are around 114.9 million peopl[...]![]()
Périodique
A. TAYLOR ; S. HUTCHINSON ; LINGAPPA J. ; S. WADD ; S. AHMED ; L. GRUER ; T. H. Jr TAYLOR ; K. ROY ; G. GILCHRIST ; MCGUIGAN C. ; PENRICE G. ; D. GOLDBERG | 2004ENGLISH : Between April and September 2000, 60 injecting drug users in Scotland died or were hospitalized with severe illness. Laboratory investigations suggested that Clostridium novyi and other bacteria were important aetiological agents. To[...]![]()
Article : Périodique
K. M. E. TURNER ; S. HUTCHINSON ; P. VICKERMAN ; V. HOPE ; N. CRAINE ; N. E. PALMATEER ; M. MAY ; A. TAYLOR ; D. DE ANGELIS ; S. CAMERON ; J. PARRY ; M. LYONS ; D. GOLDBERG ; E. ALLEN ; M. HICKMAN |AIMS To investigate whether opiate substitution therapy (OST) and needle and syringe programmes (NSP) can reduce hepatitis C virus (HCV) transmission among injecting drug users (IDUs). DESIGN Meta-analysis and pooled analysis, with logistic re[...]![]()
Périodique
D. GOLDBERG ; S. BURNS ; A. TAYLOR ; S. CAMERON ; HARGREAVES D. ; S. HUTCHINSON | 2001ENGLISH : In 1998, we reported that anti-HCV prevalence among injectors from Glasgow had declined between 1990 and 1995. We set out to ascertain if the anti-HCV prevalence among injectors from Edinburgh had declined similarly during this perio[...]